Annual Report 2024

MANAGEMENT DISCUSSION AND ANALYSIS 13 The United Laboratories International Holdings Limited Annual Report 2024 Big Health The main products include the United Health & Beauty series of healthcare products. In view of the aging of the population and the growing demand for healthcare consumption, the Group established the Big Health Division during the year, which has deployed five major product lines: general dietary supplements, healthcare food products, cross-border nutritional supplements, medical devices, medical and aesthetic skincare products. Currently, we have marketed 18 products, covering categories such as bone and joint nutrition, intestinal regulation, cardiovascular health, vision protection and immunity enhancement. At present, we have built a matrix of e-commerce, live broadcasting and new retail online platforms represented by Tmall, JD.com , Tik Tok and WeChat Mall, and deepened our coverage of pharmacy chains and health vertical pipelines. During the year, the Big Health segment recorded sales of RMB20.0 million. Animal Healthcare The Group is principally engaged in the research and development, production, sales and technical services of economic and companion animal medicines, covering medicines for livestock, poultry, aquatic products and pets. During the year, we launched 22 new products for animal healthcare and obtained one certificate for Class V new veterinary drugs. During the year, the animal healthcare segment recorded sales of RMB1,382.2 million, representing a year-on-year increase of 17.1%. The construction of the production bases under construction is progressing smoothly and they are expected to be commissioned in 2025. In addition, we are making active deployment in the overseas market and have already obtained a total of 6 overseas registration approvals for animal healthcare products in Vietnam and Australia.